References
- Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. doi:https://doi.org/10.1038/s41572-020-0145-5.
- Jeschke MG, Pinto R, Kraft R, et al. Morbidity and survival probability in burn patients in modern burn care. Crit Care Med. 2015;43:808–815. doi:https://doi.org/10.1097/ccm.0000000000000790.
- Yao Y, Liu Y, Zhou J, et al. The epidemiology of civilian inpatients’ burns in Chinese military hospitals, 2001-2007. Burns. 2011;37(6):1023–1032. doi:https://doi.org/10.1016/j.burns.2011.03.021.
- Cheng W, Shen C, Zhao D, et al. The epidemiology and prognosis of patients with massive burns: a multicenter study of 2483 cases. Burns. 2019;45(3):705–716. doi:https://doi.org/10.1016/j.burns.2018.08.008.
- Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518. doi:https://doi.org/10.1016/0140-6736(93)90277-N.
- van Engelen TSR, Wiersinga WJ, Scicluna BP, van der Poll T. Biomarkers in Sepsis. Crit Care Clin. 2018;34(1):139–152. doi:https://doi.org/10.1016/j.ccc.2017.08.010.
- Tujula B, Hämäläinen S, Kokki H, Pulkki K, Kokki M. Review of clinical practice guidelines on the use of procalcitonin in infections. Infect Dis (Lond). 2020;52(4):227–234. doi:https://doi.org/10.1080/23744235.2019.1704860.
- Kouritas V, Zissis C, Bellenis I. Procalcitonin measurement in pleural fluid to predict infectious complications of the chest post lung resection. J Invest Surg. 2021;34(12):1317–1321. doi:https://doi.org/10.1080/08941939.2020.1801912.
- Hamade B, Huang DT. Procalcitonin: where are we now? Crit Care Clin. 2020;36(1):23–40. doi:https://doi.org/10.1016/j.ccc.2019.08.003.
- Annborn M, Dankiewicz J, Erlinge D, et al. Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia-reperfusion injury and outcome. Resuscitation. 2013;84(6):782–787. doi:https://doi.org/10.1016/j.resuscitation.2013.01.004.
- Hoshino K, Irie Y, Mizunuma M, Kawano K, Kitamura T, Ishikura H. Incidence of elevated procalcitonin and presepsin levels after severe trauma: a pilot cohort study. Anaesth Intensive Care. 2017;45(5):600–604. doi:https://doi.org/10.1177/0310057X1704500510.
- Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998;24(7):680–684. doi:https://doi.org/10.1007/s001340050644.
- Muroi C, Lemb JB, Hugelshofer M, Seule M, Bellut D, Keller E. Early systemic procalcitonin levels in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014;21(1):73–77. doi:https://doi.org/10.1007/s12028-013-9844-z.
- Sandkovsky U, Kalil AC, Florescu DF. The use and value of procalcitonin in solid organ transplantation. Clin Transplant. 2015;29(8):689–696. doi:https://doi.org/10.1111/ctr.12568.
- Sternby H, Hartman H, Johansen D, Thorlacius H, Regner S. Predictive capacity of biomarkers for severe acute pancreatitis. Eur Surg Res. 2016;56(3–4):154–163. doi:https://doi.org/10.1159/000444141.
- Tan J, Li N, Gong Y, Yuan L, Zhou J, Luo G. Procalcitonin kinetics early after severe burn injury and its value in diagnosis of sepsis. Burns. 2021;47(8):1802–1809. doi:https://doi.org/10.1016/j.burns.2021.02.024.
- Evavold CL, Kagan JC. How inflammasomes inform adaptive immunity. J Mol Biol. 2018;430(2):217–237. doi:https://doi.org/10.1016/j.jmb.2017.09.019.
- Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol. 2004;4(6):469–478. doi:https://doi.org/10.1038/nri1372.
- Committee I, Steering S, Advisory S. ISBI practice guidelines for burn care. Burns. 2016;42:953–1021. doi:https://doi.org/10.1016/j.burns.2016.05.013.
- Greenhalgh DG. Management of burns. N Engl J Med. 2019;380(24):2349–2359. doi:https://doi.org/10.1056/NEJMra1807442.
- Tagami T, Matsui H, Fushimi K, Yasunaga H. Validation of the prognostic burn index: a nationwide retrospective study. Burns. 2015;41(6):1169–1175. doi:https://doi.org/10.1016/j.burns.2015.02.017.
- Greenhalgh DG, Saffle JR, Holmes J, American Burn Association Consensus Conference on Burn Sepsis and Infection Group, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28(6):776–790. doi:https://doi.org/10.1097/BCR.0b013e3181599bc9.
- Müller B, Becker KL, Schächinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000;28:977–983. doi:https://doi.org/10.1097/00003246-200004000-00011.
- Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308–1318. doi:https://doi.org/10.1515/cclm-2018-1181.
- Mann EA, Baun MM, Meininger JC, Wade CE. Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock. 2012;37(1):4–16. doi:https://doi.org/10.1097/SHK.0b013e318237d6bf.
- Albright JM, Davis CS, Bird MD, et al. The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury. Crit Care Med. 2012;40:1113–1121. doi:https://doi.org/10.1097/CCM.0b013e3182374a67.
- Xu L, Jin J, Wu G, et al. Elevated serum procalcitonin early after extensive burn: influencing factors and clinical significance. Burns. 2021;47(6):1399–1407. doi:https://doi.org/10.1016/j.burns.2020.12.010.
- LeGall JR, Loirat P, Alpérovitch A. APACHE II-a severity of disease classification system. Crit Care Med. 1986;14(8):754–755. doi:https://doi.org/10.1097/00003246-198608000-00027.
- Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. doi:https://doi.org/10.1007/BF01709751.
- Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Critical Care Med. 1995;23(10):1638–1652. doi:https://doi.org/10.1097/00003246-199510000-00007.
- Castelli GP, Pognani C, Cita M, Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med. 2009;37:1845–1849. doi:https://doi.org/10.1097/CCM.0b013e31819ffd5b.
- Brusselaers N, Hoste EA, Monstrey S, et al. Outcome and changes over time in survival following severe burns from 1985 to 2004. Intensive Care Med. 2005;31(12):1648–1653. doi:https://doi.org/10.1007/s00134-005-2819-6.
- Jones SW, Williams FN, Cairns BA, Cartotto R. Inhalation injury: pathophysiology, diagnosis, and treatment. Clin Plast Surg. 2017;44(3):505–511. doi:https://doi.org/10.1016/j.cps.2017.02.009.
- Shirani KZ, Pruitt BA, Jr, Mason AD, Jr. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg. 1987;205(1):82–87. doi:https://doi.org/10.1097/00000658-198701000-00015.
- Hensel M, Volk T, Döcke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology. 1998;89(1):93–104. doi:https://doi.org/10.1097/00000542-199807000-00016.
- Nylen ES, O’Neill W, Jordan MH, et al. Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res. 1992;24(9):439–443. doi:https://doi.org/10.1055/s-2007-1003354.
- Wu MY, Yiang GT, Liao WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650–1667. doi:https://doi.org/10.1159/000489241.
- Saeed K, Ahmad N, Dryden M. The value of procalcitonin measurement in localized skin and skin structure infection, diabetic foot infections, septic arthritis and osteomyelitis. Expert Rev Mol Diagn. 2014;14(1):47–54. doi:https://doi.org/10.1586/14737159.2014.864238.
- Lavrentieva A, Papadopoulou S, Kioumis J, Kaimakamis E, Bitzani M. PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment. Burns. 2012;38(3):356–363. doi:https://doi.org/10.1016/j.burns.2011.08.021.
- Tavares E, Miñano FJ. Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studies. Clin Sci (Lond). 2010;119(12):519–534. doi:https://doi.org/10.1042/cs20100007.